Characterisation of Cannabis-Based Products Marketed for Medical and Non-Medical Use Purchased in Portugal
Molecules · 2024
DOI: 10.3390/molecules29122737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Bruno Pires und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação em Ciências da Saúde, Faculdade de Ciências da Saúde da Universidade da Beira Interior (CICS-UBI), 6200-506 Covilhã, Portugal. Hauptthemen laut MEDLINE: Cannabinoids, Cannabis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Portuguese Foundation for Science and Technology (FCT).
Abstract (Originalsprache)
Cannabis-based products have gained attention in recent years for their perceived therapeutic benefits (with cannabinoids such as THC and CBD) and widespread availability. However, these products often lack accurate labelling regarding their cannabinoid content. Our study, conducted with products available in Portugal, revealed significant discrepancies between label claims and actual cannabinoid compositions. A fully validated method was developed for the characterisation of different products acquired from pharmacies and street shops (beverages, herbal samples, oils, and cosmetic products) using high-performance liquid chromatography coupled with a diode array detector. Linearity ranged from 0.4 to 100 µg/mL (0.04–10 µg/mg) (THC, 8-THC, CBD, CBG, CBDA, CBGA), 0.1–100 µg/mL (0.01–10 µg/mg) (CBN), 0.4–250 µg/mL (0.04–25 µg/mg) (THCA-A), and 0.8–100 µg/mL (0.08–10 µg/mg) (CBCA). Among sampled beverages, none contained detectable cannabinoids, despite suggestive packaging. Similarly, oils often differed from the declared cannabinoid compositions, with some containing significantly higher CBD concentrations than labelled. These inconsistencies raise serious concerns regarding consumer safety and informed decision-making. Moreover, our findings underscore the need for stringent regulation and standardised testing protocols to ensure the accuracy and safety of cannabis-based products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigação em Ciências da Saúde, Faculdade de Ciências da Saúde da Universidade da Beira Interior (CICS-UBI), 6200-506 Covilhã, Portugal.
- Laboratorio de Fármaco-Toxicologia-UBIMedical, Universidade da Beira Interior, 6200-000 Covilhã, Portugal.
- Serviço de Química e Toxicologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses-Delegação do Centro, 3000-548 Coimbra, Portugal.
- Centro Académico Clínico das Beiras (CACB)-Grupo de Problemas Relacionados com Toxicofilias, 6200-000 Covilhã, Portugal.
- AlphaBiolabs, 14 Webster Court, Carina Park, Warrington WA5 8WD, UK.
- Serviço de Química e Toxicologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses-Delegação do Sul, 1169-201 Lisboa, Portugal.
ORCID-Profile: Bruno Pires, Patrik Oliveira, Ana Y Simão, Ana Paula Duarte, Cláudia Margalho, Tiago Rosado, Mário Barroso, Eugenia Gallardo
Förderung
- Fundação para a Ciência e a Tecnologia
- Portuguese Foundation for Science and Technology (FCT)
Zitieren
APA
Pires, B., Oliveira, P., Simão, A. Y., Reis, J., Ramos, S., Duarte, A. P., Margalho, C., Rosado, T., Barroso, M., & Gallardo, E. (2024). Characterisation of Cannabis-Based Products Marketed for Medical and Non-Medical Use Purchased in Portugal. Molecules. https://doi.org/10.3390/molecules29122737
Vancouver
Pires B, Oliveira P, Simão AY, Reis J, Ramos S, Duarte AP, et al. Characterisation of Cannabis-Based Products Marketed for Medical and Non-Medical Use Purchased in Portugal. Molecules. 2024. doi:10.3390/molecules29122737
BibTeX
@article{Pires2024,
author = {Pires, Bruno and Oliveira, Patrik and Simão, Ana Y and Reis, João and Ramos, Sofia and Duarte, Ana Paula and Margalho, Cláudia and Rosado, Tiago and Barroso, Mário and Gallardo, Eugenia},
title = {Characterisation of Cannabis-Based Products Marketed for Medical and Non-Medical Use Purchased in Portugal},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29122737}
}
EUVIMED